Accepted for/Published in: JMIR Research Protocols
Date Submitted: Mar 4, 2022
Date Accepted: Feb 25, 2023
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A mobile self-control training app to improve self-control and physical activity in people with severe mental illness: Protocol for two single-case experiment designs
ABSTRACT
Background:
Lack of physical activity (PA) is a common issue with detrimental consequences for the health of people with severe mental illness (SMI). Existing PA interventions show suboptimal effects because they require substantial cognitive skills, including goal setting and writing, while cognitive deficits are common in this population. To bolster the effectiveness of PA interventions, self-control training (SCT), in which users practice the ability to override unwanted thoughts and behaviors, can be used as an addition. Recent research has demonstrated initial effectiveness of a mobile self-control training app, but this has not been studied in psychiatric clinical practice.
Objective:
The aim of this study is to evaluate to what extent adding a mobile self-control app designed for and with people with SMI to an existing PA intervention increases physical activity and self-control levels.
Methods:
A mixed-methods approach incorporating two single-case experimental designs (SCED) and qualitative interviews is used to evaluate and optimize SCT. 12 participants with SMI will be recruited from two organizations that offer inpatient care to people with SMI. In each experiment 6 inpatients will be included. SCED I is a concurrent multiple-baseline design across participants, which explores initial effectiveness and optimal intervention duration. Using accelerometry and experience sampling questionnaires, participants’ physical activity and self-control will be monitored for at least 5 days of baseline. This is followed by sequential introduction of Google Fit, a PA intervention for 7 days, and the addition of SCIPP: the Self Control Intervention aPP, used for 28 days. SCED II is an introduction/withdrawal design, in which optimized self-control training will be introduced and withdrawn to validate findings from SCED I. In both experiments, daily average of total activity counts per hour and state level of self-control will serve as the primary and secondary outcome measures. Data will be analyzed using visual analysis and piecewise linear regression models.
Results:
The study has been designated as not subject to the Dutch Medical Research Involving Human Subjects Act by the Medical Research Ethical Committee Oost Nederland and has been approved by the University of Twente Ethical Committee Behavioral, Management and Social Sciences. Recruitment for the study has started January 2022 and we expect to publish the results early 2023.
Conclusions:
The mobile self-control training app is expected to be feasible and effective. It is self-paced, scalable, and can increase patient motivation, making it a suitable intervention to target people with SMI. SCED is a relatively novel yet very promising method for gaining insight into if and how mobile apps work, which can handle heterogenous samples and makes it possible to involve the diverse population of people with SMI without having to include a large number of participants. Clinical Trial: Central Committee on Research involving Human Subjects (CCMO Toetsingonline) NL79450.091.21.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.